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On May 22
nd 2009 we received an article by Jignesh P. Raval, Anil J. Malaviya, Nilesh H. 
Patel, Hemul V. Patel and Pradip S. Patel entitled 'Synthesis and In Vitro 
Antimycobacterial Activity of Trisubstituted s-Triazines' and an external peer review was 
started. On June 12
th 2009 the managing editor accepted a revised version of the 
manuscript and one day later, on June 13
th 2009, a copy-edited version was published 
online [1] as 'uncorrected proof' in our in press section. Several weeks later it was brought 
to our intention that a very similar paper had been published in the International Journal of 
ChemTech Research [2]. We communicated this fact to the corresponding author, Jignesh 
P. Raval, and asked for clarification (especially as ambiguities in the chemical structures 
within each paper became evident). Unfortunately, the author failed to give reasonable 
explanations. Finally, the author asked for withdrawal of the article. 
In conclusion, we have severe doubts about the integrity of the manuscript. Thus, the 
article will not be published in print. The uncorrected proof published online is retracted 
and the pages are watermarked 'Retracted'. 
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